Method for treating Peyronie's disease
First Claim
1. A method of treating a patient having a plaque mass associated with Peyronie'"'"'s disease in a penile region, comprising the steps of:
- (a) performing a battery of tests to quantify an initial state of parameters associated with Peyronie'"'"'s disease in the patient;
(b) applying shock wave treatment to the plaque mass in the penile region, thereby softening the plaque mass and disrupting any calcification in the plaque mass wherein the shock wave treatment comprises a low intensity shock wave treatment having a minimum energy of 0.10 mJmm2;
(c) applying carboxy treatment comprising injecting carbon dioxide into the plaque mass after the step of applying the shock wave treatment;
(d) repeating the battery of tests to quantify a current state of parameters associated with Peyronie'"'"'s disease in the patient and comparing the current state to the initial state; and
(e) until the current state differs from the initial state by at least a predetermined amount, repeating steps (b) through (d).
1 Assignment
0 Petitions
Accused Products
Abstract
In a method of treating a patient having diffuse plaque and/or a plaque mass associated with Peyronie'"'"'s disease in a penile region, a battery of tests is performed to quantify an initial state of parameters associated with Peyronie'"'"'s disease in the patient. Low intensity shock wave therapy is applied to the plaque mass in the penile region, thereby softening the plaque mass and disrupting any calcification in the plaque mass. Carbon dioxide is injected into the plaque mass. The battery of tests is repeated to quantify a current state of parameters associated with Peyronie'"'"'s disease in the patient and the current state is compared to the initial state. The aforementioned treatment steps are repeated until the current state differs from the initial state by at least a predetermined amount.
21 Citations
20 Claims
-
1. A method of treating a patient having a plaque mass associated with Peyronie'"'"'s disease in a penile region, comprising the steps of:
-
(a) performing a battery of tests to quantify an initial state of parameters associated with Peyronie'"'"'s disease in the patient; (b) applying shock wave treatment to the plaque mass in the penile region, thereby softening the plaque mass and disrupting any calcification in the plaque mass wherein the shock wave treatment comprises a low intensity shock wave treatment having a minimum energy of 0.10 mJmm2; (c) applying carboxy treatment comprising injecting carbon dioxide into the plaque mass after the step of applying the shock wave treatment; (d) repeating the battery of tests to quantify a current state of parameters associated with Peyronie'"'"'s disease in the patient and comparing the current state to the initial state; and (e) until the current state differs from the initial state by at least a predetermined amount, repeating steps (b) through (d). - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)
-
-
15. A treatment method for a patient having a plaque mass associated with Peyronie'"'"'s disease in a penile region, comprising the steps of:
-
(a) performing a battery of tests to quantify an initial state of parameters associated with Peyronie'"'"'s disease in the patient; (b) applying shock wave treatment to the plaque mass in the penile region, thereby softening the plaque and disrupting calcification in the plaque mass, wherein the shock wave treatment comprises a low intensity shock wave treatment having a minimum energy of 0.10 mJmm2; (c) applying a counter pulsation treatment concurrently with the step of applying shock wave treatment to further disrupt calcification in the plaque mass; (d) injecting a plurality of doses of 160 cc of carbon dioxide per dose into the plaque mass after the concurrently applied steps of applying shock wave treatment and applying a counter pulsation treatment; (e) before the concurrently applied steps of applying shock wave treatment and applying a counter-pulsation treatment, injecting a therapeutically effective dose of Verapamil into a dorsal area of the penile area; (f) repeating the battery of tests to quantify a current state of parameters associated with Peyronie'"'"'s disease in the patient and comparing the current state to the initial state; and (g) until the current state differs from the initial state by at least a predetermined amount, repeating steps (b) through (f). - View Dependent Claims (16, 17, 18, 19, 20)
-
Specification